A Rees

871 total citations
16 papers, 669 citations indexed

About

A Rees is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A Rees has authored 16 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A Rees's work include Cancer Treatment and Pharmacology (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). A Rees is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). A Rees collaborates with scholars based in United Kingdom, Saudi Arabia and Australia. A Rees's co-authors include Emma Simpson, Katy Cooper, Karl G. Nicholson, Paul Tappenden, Robert C. Read, Sue Ward, Sarah Davis, Daniel Hind, Anne Wilkinson and Paul V Tisi and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Health Technology Assessment and Journal of Infection.

In The Last Decade

A Rees

16 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Rees United Kingdom 11 158 150 91 86 65 16 669
Gillian Worthy United Kingdom 13 129 0.8× 208 1.4× 133 1.5× 59 0.7× 15 0.2× 17 875
Xavier Badía Spain 14 105 0.7× 101 0.7× 119 1.3× 211 2.5× 31 0.5× 71 808
A Bignamini Italy 15 461 2.9× 157 1.0× 103 1.1× 27 0.3× 78 1.2× 41 874
Mitch DeKoven United States 20 219 1.4× 123 0.8× 47 0.5× 75 0.9× 82 1.3× 86 929
Tim Bancroft United States 18 179 1.1× 76 0.5× 182 2.0× 57 0.7× 57 0.9× 55 955
Laura M. Enomoto United States 18 103 0.7× 265 1.8× 159 1.7× 27 0.3× 36 0.6× 34 666
Abdelouahab Bellou France 18 100 0.6× 90 0.6× 126 1.4× 41 0.5× 9 0.1× 67 957
Alexander Kuhlmann Germany 16 188 1.2× 91 0.6× 115 1.3× 74 0.9× 81 1.2× 47 910
H S Sacks United States 6 79 0.5× 221 1.5× 70 0.8× 41 0.5× 39 0.6× 9 694
Basel Abdelazeem United States 14 129 0.8× 112 0.7× 120 1.3× 13 0.2× 64 1.0× 164 776

Countries citing papers authored by A Rees

Since Specialization
Citations

This map shows the geographic impact of A Rees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Rees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Rees more than expected).

Fields of papers citing papers by A Rees

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Rees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Rees. The network helps show where A Rees may publish in the future.

Co-authorship network of co-authors of A Rees

This figure shows the co-authorship network connecting the top 25 collaborators of A Rees. A scholar is included among the top collaborators of A Rees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Rees. A Rees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rees, A, et al.. (2019). Nurses Acceptance of Automated Medication Dispensing Cabinets. Studies in health technology and informatics. 262. 47–50. 5 indexed citations
2.
Czoski‐Murray, Carolyn, M Lloyd Jones, Christopher McCabe, et al.. (2012). Survey of current practice on pre-operative testing in ASA grade 1 and ASA grade 2. 1 indexed citations
3.
Whyte, Sophie, Abdullah Pandor, Matt Stevenson, & A Rees. (2010). Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer. Health Technology Assessment. 14(Suppl 2). 47–53. 8 indexed citations
4.
Jackson, Rachel, Katy Cooper, Paul Tappenden, et al.. (2010). Oseltamivir, zanamivir and amantadine in the prevention of influenza: A systematic review. Journal of Infection. 62(1). 14–25. 91 indexed citations
5.
Hummel, S, et al.. (2010). Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation. Health Technology Assessment. 14(47). 1–108, iii. 69 indexed citations
6.
Whyte, Sophie, Abdullah Pandor, Matt Stevenson, & A Rees. (2010). Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer. Health Technology Assessment. 14(Suppl 2). 47–53. 13 indexed citations
7.
Tappenden, Paul, R Jackson, Katy Cooper, et al.. (2009). Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation. Health Technology Assessment. 13(11). iii, ix–xii, 1. 103 indexed citations
8.
Ara, Roberta, Rachid Rafia, Sue Ward, et al.. (2009). Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective. Expert Review of Pharmacoeconomics & Outcomes Research. 9(5). 423–433. 3 indexed citations
9.
Stevenson, Matt, Alison Scope, Michael Holmes, A Rees, & Eva Kaltenthaler. (2009). Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal. Health Technology Assessment. 13(Suppl 3). 43–48. 6 indexed citations
10.
Pilgrim, Hazel, M Lloyd-Jones, & A Rees. (2009). Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation. Health Technology Assessment. 13(10). iii, ix–xi, 1. 57 indexed citations
11.
Ara, Roberta, Abdullah Pandor, John Stevens, A Rees, & Rachid Rafia. (2009). Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation. Health Technology Assessment. 13(34). 1–74, 75. 31 indexed citations
12.
Goldbart, Juliet, et al.. (2009). A systematic review of environmental interventions to improve child language outcomes for children with or at risk of primary language impairment. Journal of Research in Special Educational Needs. 9(2). 66–79. 25 indexed citations
13.
Stevenson, Matt, Alison Scope, Michael Holmes, A Rees, & Eva Kaltenthaler. (2009). Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal. Health Technology Assessment. 13(Suppl 3). 43–48. 28 indexed citations
14.
Ara, Roberta, Abdullah Pandor, Indra Tumur, et al.. (2008). Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or Contraindications. American Journal of Cardiovascular Drugs. 8(6). 419–427. 20 indexed citations
15.
Ward, Sue, Emma Simpson, Sarah Davis, et al.. (2007). Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation. Health Technology Assessment. 11(40). 1–144. 144 indexed citations
16.
Tisi, Paul V, Catherine Beverley, & A Rees. (2006). Injection sclerotherapy for varicose veins. Cochrane Database of Systematic Reviews. CD001732–CD001732. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026